美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA214091"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
72162-2194-1 72162-2194 HUMAN PRESCRIPTION DRUG Carbidopa and Levodopa Carbidopa and Levodopa TABLET, EXTENDED RELEASE ORAL 20231215 N/A ANDA ANDA214091 Bryant Ranch Prepack CARBIDOPA; LEVODOPA 25 mg/1; 100 mg/1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2194-1)
0615-8460-39 0615-8460 HUMAN PRESCRIPTION DRUG Carbidopa and Levodopa Carbidopa and Levodopa TABLET, EXTENDED RELEASE ORAL 20230328 N/A ANDA ANDA214091 NCS HealthCare of KY, LLC dba Vangard Labs CARBIDOPA; LEVODOPA 25 mg/1; 100 mg/1 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8460-39)
72162-2193-1 72162-2193 HUMAN PRESCRIPTION DRUG Carbidopa and Levodopa Carbidopa and Levodopa TABLET, EXTENDED RELEASE ORAL 20231215 N/A ANDA ANDA214091 Bryant Ranch Prepack CARBIDOPA; LEVODOPA 50 mg/1; 200 mg/1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2193-1)
0615-8461-39 0615-8461 HUMAN PRESCRIPTION DRUG Carbidopa and Levodopa Carbidopa and Levodopa TABLET, EXTENDED RELEASE ORAL 20230403 N/A ANDA ANDA214091 NCS HealthCare of KY, LLC dba Vangard Labs CARBIDOPA; LEVODOPA 50 mg/1; 200 mg/1 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8461-39)
50228-460-01 50228-460 HUMAN PRESCRIPTION DRUG Carbidopa and Levodopa Carbidopa and Levodopa TABLET, EXTENDED RELEASE ORAL 20211005 N/A ANDA ANDA214091 ScieGen Pharmaceuticals Inc CARBIDOPA; LEVODOPA 25 mg/1; 100 mg/1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-460-01)
50228-460-10 50228-460 HUMAN PRESCRIPTION DRUG Carbidopa and Levodopa Carbidopa and Levodopa TABLET, EXTENDED RELEASE ORAL 20211005 N/A ANDA ANDA214091 ScieGen Pharmaceuticals Inc CARBIDOPA; LEVODOPA 25 mg/1; 100 mg/1 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-460-10)
50228-460-30 50228-460 HUMAN PRESCRIPTION DRUG Carbidopa and Levodopa Carbidopa and Levodopa TABLET, EXTENDED RELEASE ORAL 20211005 N/A ANDA ANDA214091 ScieGen Pharmaceuticals Inc CARBIDOPA; LEVODOPA 25 mg/1; 100 mg/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-460-30)
50228-461-01 50228-461 HUMAN PRESCRIPTION DRUG Carbidopa and Levodopa Carbidopa and Levodopa TABLET, EXTENDED RELEASE ORAL 20211005 N/A ANDA ANDA214091 ScieGen Pharmaceuticals Inc CARBIDOPA; LEVODOPA 50 mg/1; 200 mg/1 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-461-01)
50228-461-10 50228-461 HUMAN PRESCRIPTION DRUG Carbidopa and Levodopa Carbidopa and Levodopa TABLET, EXTENDED RELEASE ORAL 20211005 N/A ANDA ANDA214091 ScieGen Pharmaceuticals Inc CARBIDOPA; LEVODOPA 50 mg/1; 200 mg/1 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-461-10)
50228-461-30 50228-461 HUMAN PRESCRIPTION DRUG Carbidopa and Levodopa Carbidopa and Levodopa TABLET, EXTENDED RELEASE ORAL 20211005 N/A ANDA ANDA214091 ScieGen Pharmaceuticals Inc CARBIDOPA; LEVODOPA 50 mg/1; 200 mg/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50228-461-30)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase